2m 2m 2m 2m 2m 2m 2m
FENNEC PHARMA (FENC)
NASDAQ
$9.14-$0.005 (-0.05%)
Price as of Jun 03, 2026 7:46 PM EDT- $343.0MMarket Cap
- 26.73%1-Year Change
- BiotechnologyIndustry
FENNEC PHARMA (FENC)
$9.14-$0.005 (-0.05%)
FENC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.14 | ||
Change | -$0.84 (-8.42%) | ||
Open | $9.96 | ||
High | $9.96 | ||
Low | $9.06 | ||
Previous Close | $9.98 | ||
Volume | 238,835 | ||
30-Day Average Volume | 379,271 | ||
1-Week Change | -8.32% | ||
1-Month Change | 39.76% | ||
1-Year Change | 19.09% | ||
3-Year Change | 11.19% | ||
5-Year Change | 23.68% | ||
Fundamentals | |||
Shares Outstanding | 34.5M | ||
Total Assets | $71.8M | ||
Market Cap | $343.0M | ||
Enterprise Value | $302.8M | ||
Period: QTR TTM FY | |||
Revenue | $15.1M | ||
Net Income | $201,000.00 | ||
Free Cash Flow | $2.4M | ||
EBIT | $208,000.00 | ||
EBITDA | $234,000.00 | ||
Net Working Capital | $57.3M | ||
EPS | $0.01 | ||
Enterprise Value/EBITDA | 1,294 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 9 | ||
P/E | 993 | ||
PEG | 9 | ||
Price/Free Cash Flow | 144 | ||
Price/Operating Cash Flow | 144 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue